Cargando…
CD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART
Plasma HIV viral load is related to declining CD4 lymphocytes. The extent to which CD8 cells, in addition to RNA viral load, predict the depletion of CD4 cells is not well characterized so far. We examine if CD8 cell count is a prognostic factor for CD4 cell counts during an HIV infection. A longitu...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079322/ https://www.ncbi.nlm.nih.gov/pubmed/27759638 http://dx.doi.org/10.1097/MD.0000000000005094 |
_version_ | 1782462543874228224 |
---|---|
author | Sauter, Rafael Huang, Ruizhu Ledergerber, Bruno Battegay, Manuel Bernasconi, Enos Cavassini, Matthias Furrer, Hansjakob Hoffmann, Matthias Rougemont, Mathieu Günthard, Huldrych F Held, Leonhard |
author_facet | Sauter, Rafael Huang, Ruizhu Ledergerber, Bruno Battegay, Manuel Bernasconi, Enos Cavassini, Matthias Furrer, Hansjakob Hoffmann, Matthias Rougemont, Mathieu Günthard, Huldrych F Held, Leonhard |
author_sort | Sauter, Rafael |
collection | PubMed |
description | Plasma HIV viral load is related to declining CD4 lymphocytes. The extent to which CD8 cells, in addition to RNA viral load, predict the depletion of CD4 cells is not well characterized so far. We examine if CD8 cell count is a prognostic factor for CD4 cell counts during an HIV infection. A longitudinal analysis is conducted using data from the Swiss HIV cohort study collected between January 2000 and October 2014. Linear mixed regression models were applied to observations from HIV-1-infected treatment naive patients (NAIVE) and cART-treated patients to predict the short-term evolution of CD4 cell counts. For each subgroup, it was quantified to which extent CD8 cell counts or CD4/CD8 ratios are prognostic factors for disease progression. In both subgroups, 2500 NAIVE and 8902 cART patients, past CD4 cells are positively (P < 0.0001) and past viral load is negatively (P < 0.0001) associated with the outcome. Including additionally past CD8 cell counts improves the fit significantly (P < 0.0001) and increases the marginal explained variation 31.7% to 40.7% for the NAIVE and from 44.1% to 50.7% for the cART group. The past CD4/CD8 ratio (instead of the past CD8 level) is positively associated with the outcome, increasing the explained variation further to 41.8% for NAIVE and 51.9% for cART. |
format | Online Article Text |
id | pubmed-5079322 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-50793222016-11-03 CD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART Sauter, Rafael Huang, Ruizhu Ledergerber, Bruno Battegay, Manuel Bernasconi, Enos Cavassini, Matthias Furrer, Hansjakob Hoffmann, Matthias Rougemont, Mathieu Günthard, Huldrych F Held, Leonhard Medicine (Baltimore) 4850 Plasma HIV viral load is related to declining CD4 lymphocytes. The extent to which CD8 cells, in addition to RNA viral load, predict the depletion of CD4 cells is not well characterized so far. We examine if CD8 cell count is a prognostic factor for CD4 cell counts during an HIV infection. A longitudinal analysis is conducted using data from the Swiss HIV cohort study collected between January 2000 and October 2014. Linear mixed regression models were applied to observations from HIV-1-infected treatment naive patients (NAIVE) and cART-treated patients to predict the short-term evolution of CD4 cell counts. For each subgroup, it was quantified to which extent CD8 cell counts or CD4/CD8 ratios are prognostic factors for disease progression. In both subgroups, 2500 NAIVE and 8902 cART patients, past CD4 cells are positively (P < 0.0001) and past viral load is negatively (P < 0.0001) associated with the outcome. Including additionally past CD8 cell counts improves the fit significantly (P < 0.0001) and increases the marginal explained variation 31.7% to 40.7% for the NAIVE and from 44.1% to 50.7% for the cART group. The past CD4/CD8 ratio (instead of the past CD8 level) is positively associated with the outcome, increasing the explained variation further to 41.8% for NAIVE and 51.9% for cART. Wolters Kluwer Health 2016-10-21 /pmc/articles/PMC5079322/ /pubmed/27759638 http://dx.doi.org/10.1097/MD.0000000000005094 Text en Copyright © 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
spellingShingle | 4850 Sauter, Rafael Huang, Ruizhu Ledergerber, Bruno Battegay, Manuel Bernasconi, Enos Cavassini, Matthias Furrer, Hansjakob Hoffmann, Matthias Rougemont, Mathieu Günthard, Huldrych F Held, Leonhard CD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART |
title | CD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART |
title_full | CD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART |
title_fullStr | CD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART |
title_full_unstemmed | CD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART |
title_short | CD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART |
title_sort | cd4/cd8 ratio and cd8 counts predict cd4 response in hiv-1-infected drug naive and in patients on cart |
topic | 4850 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079322/ https://www.ncbi.nlm.nih.gov/pubmed/27759638 http://dx.doi.org/10.1097/MD.0000000000005094 |
work_keys_str_mv | AT sauterrafael cd4cd8ratioandcd8countspredictcd4responseinhiv1infecteddrugnaiveandinpatientsoncart AT huangruizhu cd4cd8ratioandcd8countspredictcd4responseinhiv1infecteddrugnaiveandinpatientsoncart AT ledergerberbruno cd4cd8ratioandcd8countspredictcd4responseinhiv1infecteddrugnaiveandinpatientsoncart AT battegaymanuel cd4cd8ratioandcd8countspredictcd4responseinhiv1infecteddrugnaiveandinpatientsoncart AT bernasconienos cd4cd8ratioandcd8countspredictcd4responseinhiv1infecteddrugnaiveandinpatientsoncart AT cavassinimatthias cd4cd8ratioandcd8countspredictcd4responseinhiv1infecteddrugnaiveandinpatientsoncart AT furrerhansjakob cd4cd8ratioandcd8countspredictcd4responseinhiv1infecteddrugnaiveandinpatientsoncart AT hoffmannmatthias cd4cd8ratioandcd8countspredictcd4responseinhiv1infecteddrugnaiveandinpatientsoncart AT rougemontmathieu cd4cd8ratioandcd8countspredictcd4responseinhiv1infecteddrugnaiveandinpatientsoncart AT gunthardhuldrychf cd4cd8ratioandcd8countspredictcd4responseinhiv1infecteddrugnaiveandinpatientsoncart AT heldleonhard cd4cd8ratioandcd8countspredictcd4responseinhiv1infecteddrugnaiveandinpatientsoncart |